ZA9312B - Treatment of involuntary movements with 5HT1a receptor agonists - Google Patents

Treatment of involuntary movements with 5HT1a receptor agonists

Info

Publication number
ZA9312B
ZA9312B ZA9312A ZA9312A ZA9312B ZA 9312 B ZA9312 B ZA 9312B ZA 9312 A ZA9312 A ZA 9312A ZA 9312 A ZA9312 A ZA 9312A ZA 9312 B ZA9312 B ZA 9312B
Authority
ZA
South Africa
Prior art keywords
treatment
receptor agonists
involuntary movements
5ht1a receptor
5ht1a
Prior art date
Application number
ZA9312A
Other languages
English (en)
Inventor
Mertin Galvan
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA9312B publication Critical patent/ZA9312B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9312A 1992-01-07 1993-01-04 Treatment of involuntary movements with 5HT1a receptor agonists ZA9312B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400032 1992-01-07

Publications (1)

Publication Number Publication Date
ZA9312B true ZA9312B (en) 1993-08-05

Family

ID=8211593

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9312A ZA9312B (en) 1992-01-07 1993-01-04 Treatment of involuntary movements with 5HT1a receptor agonists

Country Status (5)

Country Link
AU (1) AU3241093A (xx)
CA (1) CA2126554A1 (xx)
MX (1) MX9300035A (xx)
WO (1) WO1993013766A1 (xx)
ZA (1) ZA9312B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
WO2015197079A1 (en) * 2014-06-26 2015-12-30 Contera Pharma Aps Use of buspirone metabolites
CN111116451A (zh) * 2020-01-16 2020-05-08 宁波大学 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642497A1 (de) * 1986-12-12 1988-06-23 Hoechst Ag Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte

Also Published As

Publication number Publication date
MX9300035A (es) 1994-05-31
AU3241093A (en) 1993-08-03
WO1993013766A1 (en) 1993-07-22
CA2126554A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
GB2255503B (en) Improved use of ß2-bronchodilator drugs
GR3035574T3 (en) Use of substituted benzimidazoles.
EP0420064A3 (en) Substituted 2-amidotetralins as melatonin agonists and antagonists
GB8928934D0 (en) Treatment of birds
GB9103075D0 (en) Trinitrobenzene derivatives and their therapeutic use
ZA9312B (en) Treatment of involuntary movements with 5HT1a receptor agonists
GB2262237B (en) Skin treatment instrument
GB9006251D0 (en) Monitor of physiological functions
IL104755A0 (en) Treatment of glaucoma
EP0328132A3 (en) Therapeutic agent for thrombocytopenia
ZA914435B (en) Treatment of disease
ZA922512B (en) Hyperpigmentation of skin
NZ250159A (en) Use of furan-3-carboxamides as microbicides
NZ255753A (en) Use of substituted azaspiranes for psoriasis treatment
GB2220652B (en) Treatment of pastures
GB9024895D0 (en) Therapeutic use of fibroblast growth factor
GB9100752D0 (en) Treatment of scar tissue
GB9216360D0 (en) Treatment of blood
GB9206021D0 (en) Treatment of scar tissue
GB2266241B (en) Treatment of pastures
GB8901483D0 (en) Treatment of scar tissue
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
IE900102L (en) Treatment of skin disorders
GB9111015D0 (en) Skin tone medical plasters
IE891758L (en) Therapeutic uses of 2', 5'-oligoadenylates